Pharma firms have asked govt for a forecast on Covid trajectory to meet demand since manufacturing remdesivir takes time, by which time a vaccine could become available.
Glenmark conducted phase 3 clinical trials of favipiravir on 150 mild to moderate Covid patients. Adverse events, or side effects, reported in 32 patients.
In an interview to ThePrint, Panjak R. Patel, chairman of Zydus Cadila, says company has already manufactured clinical batches of the vaccine candidate for phase 1 and 2 trials.
Complaint by MP to DCGI also highlights that the cost proposed by Glenmark is ‘definitely not in the interest of the poor, lower middle class and middle-class people of India’.
Oxford vaccine is under Phase II/III trials in multiple countries, where many have been given the vaccine & are being followed up with — a process that consumes time, but is standard.
For all their colonial underpinnings, postcards from Hyderabad also inadvertently preserve a trace of local memory: a glimpse of a street, a face, a forgotten name.
Indian toymakers are now exploring new markets, but they want govt to negotiate a trade deal with US soon, introduce incentives and subsidies to make the industry more competitive.
The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.
Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?
COMMENTS